Low serum chloride levels are associated with adverse prognosis in patients with acute or chronic heart failure (HF) regardless of left ventricular ejection fraction and independently of other prognostic markers such as N-terminal pro-B-type natriuretic peptide levels. |
It is not clear how hypochloraemia develops in patients with HF but it may be linked to neurohormonal activation, high-dose loop diuretic usage, and metabolic alkalosis. |
It is not known whether hypochloraemia is a marker or mediator of adverse outcome in patients with heart failure, although there are several putative mechanisms that might suggest the latter. For example, hypochloraemia might be linked to increased neurohormonal activation, diuretic resistance, and increased risk of sudden cardiac death. |
Acetazolamide may increase natriuresis and diuresis while also increasing chloride reabsorption and bicarbonate excretion and thus might be a useful treatment for patients with HF, hypochloraemia, metabolic alkalosis, and diuretic resistance. |
Introduction
Study (year) | Population (N) | Findings |
---|---|---|
Cuthbert et al. (2018) [3] | Outpatients with HeFREF and HeFNEF (N = 4705) | Compared to patients with normal chloride levels, patients with low chloride: Had more severe symptoms and higher NTproBNP levels in both HeFREF and HeFNEF phenotypes Were more likely to die or be admitted with HF regardless of HF phenotype and independent of NTproBNP and sodium levels Patients with hypochloraemia and normal sodium levels had higher bicarbonate and lower potassium levels than those with dual hypochloraemia and hyponatremia There was no association between chloride and NTproBNP levels on MV analysis but both were independently associated with adverse outcome, suggesting they assess different aspects of the HF syndrome Signal towards an association between hypochloraemia and sudden death U-shaped relationship between chloride and outcome: there was a substantial increased risk of death in patients with chloride levels < 100 mmol/l (higher than the arbitrary cut-off that defines hypochloraemia — < 96 mmol/l) |
Grodin et al. (2015) [4] | Two different cohorts of inpatients with HeFREF (Cleveland Clinic cohort N = 1318; Pennsylvania cohort: N = 876) | Compared to patients with normal chloride levels, patients with low chloride: Had lower LVEF, higher NTproBNP and longer length of hospital stay Greater risk of death independent of sodium levels in two different populations of patients admitted with HF |
Ter Maaten et al. (2016) [5] | Inpatients enrolled in the PROTECT trial (N = 2033) | Compared to patients with normal chloride levels, patients with low chloride: Had lower diuretic response (weight lost per 40 mg furosemide) despite taking higher doses of diuretic, and were more likely to have “residual congestion” on day 7 Were more likely to require inotropic support and have worsening HF symptoms during admission Were more likely to die 180 days after discharge Patients with low chloride that had resolved by the time of discharge had a similar post-discharge prognosis to those with normal chloride levels throughout admission There was no difference in admission NTproBNP or BNP across quintiles of chloride |
Grodin et al. (2016) [6] | Outpatients (N = 1673) | Compared to patients with normal chloride levels, patients with low chloride: Were more likely to take loop diuretics Were more likely to die during 5-year follow-up regardless of sodium levels, after adjustment for BNP and LVEF There was no difference in baseline renal function, LVEF, or BNP levels between patients with low chloride levels and those with normal chloride levels |
Testani et al. (2016) [7] | Outpatients enrolled in the BEST trial (N = 2699) | Compared to patients with normal chloride levels, patients with low chloride: Had worse renal function, lower LVEF and more severe symptoms Were more likely to die during follow-up Modest association between chloride and sodium levels (r = 0.53; P < 0.001) and only half of patients with hypochloraemia were also hyponatremic Low sodium, was not associated with mortality after multivariable adjustment |
Hanberg et al. (2016) [8] | Outpatients with progressive symptoms attending for daily IV furosemide or PO torasemide (N = 162) | Compared to patients with normal chloride levels, patients with low chloride: Were less likely to take either ACEI or βB but more likely to take digoxin or high-dose loop diuretics Had worse renal function Had greater fractional excretion of chloride and potassium but similar fractional excretion of sodium pre-diuretic but lower fractional excretion of all three ions post-diuretic Had lower diuretic efficiency (mmol of Na+ per doubling of loop diuretic dose) Were at greater risk of all-cause mortality independent of sodium levels or renal function There was no difference in baseline LVEF or NTproBNP between patients with low chloride levels and those with normal chloride levels Chloride and renin levels were inversely correlated (r = − 0.46; P = 0.001) independent of sodium levels or renal function |
Hanberg et al. (2016) [8] | Outpatients with stable HF given 21 g lysine chloride per day (115 mmol/l chloride) for 3 days (N = 10) | Serum chloride increased by 2.2 mmol/l from baseline (P = 0.01) but there was no difference in urine volume Renin levels were paradoxically higher after chloride supplementation NTproBNP levels decreased by 25% in eight patients (P = 0.01) |
Grodin et al. (2017) [9] | Inpatients enrolled in the ROSE-AHF trial (N = 360) | Compared to patients with normal chloride levels, patients with low chloride: Were more likely to take high-dose loop diuretic on admission and had greater cumulative doses of loop diuretic during admission Had lower diuretic efficiency defined as millilitres of urine passed per 40 mg of furosemide Were more likely to die or be readmitted with HF during 60-day follow-up independent of sodium levels There was no difference in symptom severity, NTproBNP levels, renal function, rate of worsening HF as inpatient, or rate of freedom from congestion after 72 h of treatment between patients with low chloride levels and those with normal levels Average chloride change was − 0.9 mmol/l per day during 7 days of treatment, average diuretic dose on admission 80 mg furosemide equivalents Change in chloride levels was not associated with outcome |
Ferreira et al. (2017) [10] | Patients enrolled in the EPHESUS and CAPRICORN trials (N = 7195) | Compared to patients with normal chloride levels, patients with low chloride: Were older, more likely to have AF, worse renal function, and LVEF Were more likely to take diuretics and digoxin Low serum chloride was only associated with increased mortality (not hospitalization) in the context of low sodium |
Grodin et al. (2018) [11] | Outpatients with HeFNEF enrolled in the TOPCAT trial (N = 942 from North America with available chloride data) | Compared to patients with normal chloride levels, patients with low chloride: Had more severe symptoms and more likely to be taking diuretic at a higher average daily dose Had high E/e′ ratio indicating greater LV filling pressures Were at greater risk of the composite endpoint of cardiovascular death, hospitalization with HF, or aborted cardiac arrest independent of sodium or NTproBNP levels |
Marchenko et al. (2020) [12] | Consecutive inpatients at a single centre (N = 1241) | Compared to patients with normal chloride levels, patients with low chloride: Had higher average daily loop diuretic dose during inpatient stay Had higher average weight loss during inpatient stay — in contrast to other reports in patients admitted with HF detailed above Had a higher LVEF – in contrast to other reports detailed above Had greater 30-day readmission or death rate and 12-month death rate |